Valuation Update With 7 Day Price Move • Mar 11
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to ₹2.03, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 25x in the Software industry in India. Total loss to shareholders of 30% over the past year. New Risk • Feb 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (₹262m revenue, or US$2.9m). Market cap is less than US$100m (₹920.3m market cap, or US$10.1m). Reported Earnings • Feb 11
Third quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.013 in 3Q 2025) Third quarter 2026 results: EPS: ₹0.01 (down from ₹0.013 in 3Q 2025). Revenue: ₹43.8m (down 27% from 3Q 2025). Net income: ₹1.90m (down 62% from 3Q 2025). Profit margin: 4.3% (down from 8.3% in 3Q 2025). The decrease in margin was driven by lower revenue. Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹2.39, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 33x in the Software industry in India. Total loss to shareholders of 33% over the past year. 공시 • Feb 01
Orchasp Limited to Report Q3, 2026 Results on Feb 10, 2026 Orchasp Limited announced that they will report Q3, 2026 results at 9:15 AM, Indian Standard Time on Feb 10, 2026 공시 • Dec 19
Orchasp Limited announced that it expects to receive INR 86 million in funding Orchasp Limited in its Board Meeting announced a private placement of 26,875,000 Common Shares of the company at a price per share of INR 3.20 for gross proceeds of INR 86,000,000 on preferential basis on December 18, 2025. The transaction includes participation from individual investor Mrs. P. Rajeswari. Buy Or Sell Opportunity • Dec 18
Now 24% overvalued after recent price rise Over the last 90 days, the stock has risen 6.0% to ₹2.84. The fair value is estimated to be ₹2.29, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable. Buy Or Sell Opportunity • Nov 25
Now 24% overvalued Over the last 90 days, the stock has fallen 2.7% to ₹2.88. The fair value is estimated to be ₹2.32, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable. New Risk • Nov 21
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹850.0m (US$9.49m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Market cap is less than US$10m (₹850.0m market cap, or US$9.49m). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Revenue is less than US$5m (₹283m revenue, or US$3.2m). Reported Earnings • Nov 12
Second quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.37 loss in 2Q 2025) Second quarter 2026 results: EPS: ₹0.01 (up from ₹0.37 loss in 2Q 2025). Revenue: ₹75.6m (up 65% from 2Q 2025). Net income: ₹2.08m (up ₹144.8m from 2Q 2025). Profit margin: 2.7% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue. 공시 • Oct 28
Orchasp Limited to Report Q2, 2026 Results on Nov 11, 2025 Orchasp Limited announced that they will report Q2, 2026 results on Nov 11, 2025 New Risk • Oct 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 66% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Revenue is less than US$5m (₹254m revenue, or US$2.9m). Market cap is less than US$100m (₹1.20b market cap, or US$13.6m). 공시 • Sep 01
Orchasp Limited, Annual General Meeting, Sep 30, 2025 Orchasp Limited, Annual General Meeting, Sep 30, 2025, at 10:30 Indian Standard Time. Reported Earnings • Aug 12
First quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.007 in 1Q 2025) First quarter 2026 results: EPS: ₹0.02 (up from ₹0.007 in 1Q 2025). Revenue: ₹77.5m (up 123% from 1Q 2025). Net income: ₹5.42m (up 138% from 1Q 2025). Profit margin: 7.0% (up from 6.6% in 1Q 2025). The increase in margin was driven by higher revenue. New Risk • Jul 28
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 67% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$9.92m). Minor Risk Revenue is less than US$5m (₹211m revenue, or US$2.4m). 공시 • Jul 28
Orchasp Limited to Report Q1, 2026 Results on Aug 11, 2025 Orchasp Limited announced that they will report Q1, 2026 results on Aug 11, 2025 Reported Earnings • May 29
Full year 2025 earnings released: ₹0.42 loss per share (vs ₹0.045 profit in FY 2024) Full year 2025 results: ₹0.42 loss per share (down from ₹0.045 profit in FY 2024). Revenue: ₹216.2m (up 63% from FY 2024). Net loss: ₹105.2m (down ₹112.0m from profit in FY 2024). 공시 • May 19
Orchasp Limited to Report Q4, 2025 Results on May 28, 2025 Orchasp Limited announced that they will report Q4, 2025 results on May 28, 2025 New Risk • Mar 21
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$10.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 68% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$10.00m). Minor Risk Revenue is less than US$5m (₹176m revenue, or US$2.0m). Board Change • Feb 10
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Ravikishore Vithaleswara Bhattiprolu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.